# Bela 8 Week Dosing

> **NCT02560558** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 166 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Belatacept

## Key facts

- **NCT ID:** NCT02560558
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02560558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02560558, "Bela 8 Week Dosing". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02560558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*